secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001193125-24-258757
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises $2.15M in private placement of stock and pre-funded warrants
----------------------------------------------------------------------------

- Issued 76,909 shares at $3.25/share and pre-funded warrants for 584,646 shares at $3.2499 each.
- Private placement closed Nov 14, 2024; aggregate gross proceeds of approx. $2.15 million.
- Investors include FCMI Parent Co. (controlled by Chair Albert Friedberg) and Vaccinex (Rochester) L.L.C. (controlled by CEO Maurice Zauderer).
- Pre-funded warrants exercisable immediately at $0.0001/share with a 39.99% beneficial ownership limitation.
- Agreement includes participation rights in any subsequent offering and customary resale registration rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524258757/0001193125-24-258757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524258757/d889360d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-258757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer